NCT06882317View on ClinicalTrials.gov

Long Term Follow-up Study for Subjects Administered CLBR001

Enrolling by invitationOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

August 28, 2025

Primary Completion Date

February 29, 2044

Study Completion Date

February 29, 2044

Conditions
Long Term Follow-Up
Interventions
OTHER

Long Term Follow-Up

No intervention is administered on this study. Subjects who have received CLBR001 autologous CAR-T cells in a primary Calibr treatment trial will be followed long term in line with FDA guidance.

Trial Locations (1)

27560

Virtual Research Group- Premier Research, Morrisville

All Listed Sponsors
lead

Calibr, a division of Scripps Research

OTHER

NCT06882317 - Long Term Follow-up Study for Subjects Administered CLBR001 | Biotech Hunter | Biotech Hunter